Share on StockTwits

Fibrocell Science (NASDAQ:FCSC) Director Christine St.Clare acquired 10,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average price of $3.00 per share, for a total transaction of $30,000.00. Following the purchase, the director now directly owns 10,000 shares of the company’s stock, valued at approximately $30,000. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Fibrocell Science (NASDAQ:FCSC) traded up 13.01% on Friday, hitting $3.30. 315,762 shares of the company’s stock traded hands. Fibrocell Science has a 52-week low of $2.70 and a 52-week high of $7.20. The stock’s 50-day moving average is $3.28 and its 200-day moving average is $4.39. The company’s market cap is $134.8 million.

Fibrocell Science (NASDAQ:FCSC) last released its earnings data on Monday, May 19th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.20. Analysts expect that Fibrocell Science will post $-0.80 EPS for the current fiscal year.

Fibrocell Science, Inc is an aesthetic and therapeutic development stage biotechnology company focused on developing novel skin and tissue rejuvenation products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.